Wells Fargo & Company Cuts UnitedHealth Group (NYSE:UNH) Price Target to $660.00

UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price lowered by stock analysts at Wells Fargo & Company from $694.00 to $660.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Wells Fargo & Company's price target suggests a potential upside of 22.61% from the stock's previous close.

Other analysts have also recently issued research reports about the stock. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Finally, StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Stock Down 0.8 %

Shares of UNH traded down $4.19 during trading hours on Tuesday, reaching $538.29. 2,736,742 shares of the stock traded hands, compared to its average volume of 4,677,051. The stock has a fifty day simple moving average of $539.43 and a 200 day simple moving average of $565.28. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $495.38 billion, a price-to-earnings ratio of 34.73, a PEG ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group will post 29.74 EPS for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the third quarter valued at $27,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Global Wealth Strategies & Associates raised its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at $32,000. Finally, Quarry LP increased its position in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock worth $33,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.